文献速递其他结缔组织病

特发性炎症性肌病患者的疼痛特征与阿片类药物使用情况

Pain profile and opioid medication use in patients with idiopathic inflammatory myopathies.
PubMed 文献 · Rheumatology (Oxford) · 2022-01-01

本研究由患者倡导组织Myositis Support and Understanding向其成员发放问卷调查,共468人完成、423人纳入最终分析(DM n=183、PM n=109、IBM n=131)。91.5%的肌炎参与者报告当前或既往疼痛,99%将其归因于肌炎;报告疼痛的比例按肌炎类型存在统计学差异(DM 97.2%、IBM 80.9%、PM 94.5%,P<0.001),DM较IBM疼痛可能性更高(OR 3.7,95%CI 1.3,10.2,P=0.011),年龄>60岁者疼痛可能性更低(OR 0.2,95%CI 0.1,0.6,P=0.003)。387名报告疼痛者中335人报告使用止痛药,其中69%为处方阿片类药物;男性、年龄>60岁和肌炎亚型与非阿片类药物使用可能性无关。

要点

  • 91.5%的肌炎参与者报告当前或既往疼痛,99%将疼痛归因于肌炎。
  • DM疼痛比例97.2%、PM 94.5%、IBM 80.9%(P<0.001),DM较IBM疼痛可能性更高(OR 3.7)。
  • 387名报告疼痛者中335人使用止痛药,其中69%为处方阿片类药物。

核心结论

  • 疼痛是肌炎中常报告的的症状,治疗策略不一,包括使用阿片类药物。
  • 本研究强调将疼痛作为肌炎治疗的一部分加以处理的重要性,以及需要未来研究理解治疗有效性。

研究设计与样本

  • 由患者倡导组织Myositis Support and Understanding开发并发放问卷给其成员。
  • 共468名参与者完成调查,基于所报告诊断,423名参与者(DM n=183、PM n=109、IBM n=131)纳入最终分析。
  • 进行了多变量逻辑回归分析和卡方检验。

主要发现

  • 91.5%的肌炎参与者报告当前或既往疼痛,其中99%将疼痛归因于肌炎。
  • 年龄>60岁的参与者疼痛可能性更低(OR 0.2,95%CI 0.1,0.6,P=0.003)。
  • 报告疼痛的百分比按肌炎类型存在统计学差异(DM 97.2%、IBM 80.9%、PM 94.5%,P<0.001),DM较IBM疼痛可能性更高(OR 3.7,95%CI 1.3,10.2,P=0.011)。
  • 387名报告疼痛的参与者中,335人报告使用止痛药,其中69%为处方阿片类药物。
  • 男性、年龄>60岁和肌炎亚型与非阿片类药物使用可能性无关。

关键数值与推荐

  • 疼痛可能性:年龄>60岁者OR 0.2(95%CI 0.1,0.6,P=0.003)。
  • 疼痛可能性:DM较IBM的OR 3.7(95%CI 1.3,10.2,P=0.011)。
  • 报告疼痛百分比:DM 97.2%、IBM 80.9%、PM 94.5%(P<0.001)。
  • 387名报告疼痛者中335人使用止痛药,其中69%为处方阿片类药物。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Pain is commonly reported in people living with myositis. This study assesses the presence of pain in the subtypes of myositis as well as the frequency of opioid and non-opioid pain medication use. METHODS: A survey was developed and distributed by Myositis Support and Understanding, a patient-led advocacy organization, to members of its group. Multivariate logistic regression analysis and chi-squared tests were performed. RESULTS: A total of 468 participants completed the survey. A total of 423 participants (DM n = 183, PM n = 109 and IBM n = 131) were included, based on reported diagnosis, for final analysis. Some 91.5% of myositis participants reported current or past pain, with 99% attributing their pain to myositis. There was a lower likelihood of pain in participants aged >60 years [odds ratio (OR) 0.2, 95% confidence interval (CI) 0.1, 0.6, P = 0.003]. The percentage of participants reporting pain was statistically different based on myositis type (DM 97.2%, IBM 80.9% and PM 94.5%, P < 0.001), with a higher likelihood of pain in DM compared with IBM (OR 3.7, 95% CI 1.3, 10.2, P = 0.011). There was a lower likelihood of pain in participants aged >60 years (OR 0.2, 95% CI 0.1, 0.6, P = 0.003). Of the 387 participants reporting pain, 335 reported using pain medications (69% prescribed opioids). Male sex, age >60 years and myositis subtype were not associated with likelihood of non-opioid use. CONCLUSION: Pain is a commonly reported symptom in myositis with variable treatment strategies, including opioid medications. This study highlights the importance of addressing pain as part of myositis treatment as well as the need for future studies understanding treatment effectiveness.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Bhashyam A, Lubinus M, Filmore E, et al. Pain profile and opioid medication use in patients with idiopathic inflammatory myopathies. Rheumatology (Oxford). 2022. PMID: 35579332. doi:10.1093/rheumatology/keac271

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。